Similarly, the Genome-Based Therapeutic Drugs for Depression (GENDEP) project showed that the mRNA expression of inflammation-related genes, such as IL-1b, macrophage inhibiting factor (MIF) and tumor necrosis factor (TNF) are higher in non-responders depressed patients before treatment25. The gene discussed is IL1B; the disease is major depressive disorder.